More Company News

Nexstim

Final results of successful rights issue
07 Apr 2021Read More

Nexstim

Update on promising MDD treatment results
12 Mar 2021Read More

Nexstim

Subscription rights issue of €6.6m
08 Mar 2021Read More

Nexstim

Two new NBS orders in Norway & US
04 Mar 2021Read More

Nexstim

Encouraging results from initial pilot study in severe depression
03 Mar 2021Read More

Nexstim

FY20 financial statements
26 Feb 2021Read More

Nexstim

German University Hospital orders NBS System with NexSpeech
28 Jan 2021Read More

Nexstim

New study presents impressive results of SmartFocus nTMS Language Mapping
13 Jan 2021Read More

Nexstim

Three new NBS System orders
22 Dec 2020Read More

Nexstim

Annulment of stock options held by Nexstim
15 Dec 2020Read More

1 2 3 4 … 10
Return to Nexstim
© 2019-21 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).